2022 annual financial data
MoonLake Immunotherapeutics 2022 Operating margin
MoonLake Immunotherapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -65,061,417 USD and net income was -64,506,051 USD.
Operating cash flow was -55,893,900 USD.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -65,061,417 USD
- Net income
- -64,506,051 USD
- Operating cash flow
- -55,893,900 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all MoonLake Immunotherapeutics financial years